PENNINGTON, New Jersey
| Asking Price |
$0 |
Year Established |
2017 |
|
| Annual Revenue |
$15,294 |
Reason for Selling |
Looking for a growth partner ideally. |
|
| Annual P/L |
$0 |
Attention |
Rick Carlson |
|
| Annual Cash Flow |
$5,051 |
Listing Number |
995145 |
|
| # of Employees |
1 |
Business Category |
Technology: Software |
|
Business Overview:
The Company operates in the healthcare technology space with a focus on addressing gaps in dementia and Alzheimer’s care. The company has built an ecosystem where data is collected from caregivers and patients in real-time and pushed into physicians’ EHR/EMR systems to monitor the effectiveness of the prescribed treatment plan. Alzheimer’s Disease and other dementia is the first condition that the platform will be focused on. Its platform supports physicians in managing patients through tools that enable remote monitoring and data collection, allowing for more continuous oversight rather than episodic intervention. The business generates revenue through a combination of public healthcare reimbursements and collaborations with pharmaceutical and research entities. Its model emphasizes integrating digital health solutions into clinical workflows to improve patient tracking and care coordination. The Company’s target users include healthcare providers, caregivers, and researchers working with aging populations impacted by cognitive decline.
NDA is required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Property Features and Assets:
Market Competition and Expansion:
<p>Competition: Among current tools used in dementia care, only the Company’s platform offers a fully integrated approach that supports daily use, addresses both caregiver and patient needs, tracks medical conditions, integrates with physician systems, and qualifies for reimbursement. In contrast, other solutions offer limited functionality, often focusing solely on patient engagement or assessment without clinical data integration or adaptability.<br><br>Growth & Expansion: The Company is focused on enhancing its platform, securing FDA SaMD approval, and establishing additional traction by acquiring hospital network customers and Medicare reimbursement. Over time, it aims to expand into clinical trial support and additional networks.<br></p>
Additional Details:
- The property is Leased.
- The owner is willing to train/assist the new owner.
- This is not homebased business opportunity.
- This is not a franchise resale opportunity